Key result
1,25-dihydroxyvitamin D3 decreased HCO3- absorption in the rat MTAL from 15.0 to 11.4 pmol/min/mm (P<0.001), an effect significantly potentiated by aldosterone via an ERK-dependent pathway.
Absolute Event Rate: 11.4% vs 15%
p-value: p=<0.001
Aldosterone potentiates the genomic inhibitory effect of 1,25(OH)2D3 on HCO3- absorption in the rat MTAL via a nongenomic, ERK-dependent pathway.
May influence renal bicarbonate handling in rodents; leaves open ERK-mediated vitamin D-aldosterone interactions in human acid-base disorders.
Recently, we demonstrated that aldosterone inhibits HCO3- absorption in the rat medullary thick ascending limb (MTAL) via a nongenomic pathway blocked by inhibitors of extracellular signal-regulated kinase (ERK) activation. Here we examined the effects on the MTAL of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], which regulates cell functions through nongenomic mechanisms in nonrenal systems. Addition of 1 nM 1,25(OH)2D3 to the bath decreased HCO3- absorption by 24%, from 15.0 +/- 0.3 to 11.4 +/- 0.5 pmol. min-1. mm-1 (P < 0.001). This inhibition was maximal within 60 min and was eliminated by pretreatment with actinomycin D, cycloheximide, or inhibitors of protein kinase C. In MTAL bathed with 1 nM aldosterone [added 15-20 min before 1,25(OH)2D3], the absolute (5.6 +/- 0.3 vs. 3.6 +/- 0.3 pmol. min-1. mm-1) and fractional (49 +/- 2 vs. 24 +/- 2%) decreases in HCO3- absorption induced by 1,25(OH)2D3 were significantly greater than those in the absence of aldosterone (P < 0.05). The effect of aldosterone to potentiate inhibition by 1,25(OH)2D3 was not affected by spironolactone but was eliminated by the MAPK kinase/ERK inhibitor U-0126. U-0126 did not affect inhibition of HCO3- absorption by 1,25(OH)2D3 alone. Aldosterone induced rapid activation of ERK via a transcription-independent pathway. We conclude that 1) 1,25(OH)2D3 inhibits HCO3- absorption in the MTAL via a genomic pathway involving protein kinase C, which may contribute to 1,25(OH)2D3-induced regulation of urinary net acid and/or Ca2+ excretion and 2) aldosterone potentiates inhibition by 1,25(OH)2D3 through an ERK-dependent, nongenomic pathway. These results identify a novel regulatory interaction whereby aldosterone acts via nongenomic mechanisms to enhance the genomic response to 1,25(OH)2D3. Aldosterone may influence a broad range of biological processes, including epithelial transport, by modifying the response of target tissues to 1,25(OH)2D3 stimulation.
No takes yet. Share an insight, caveat, or question.
Good et al. (2003) studied this question. 1,25-dihydroxyvitamin D3 and aldosterone vs. baseline / absence of aldosterone was evaluated on HCO3- absorption (p=<0.001). 1,25-dihydroxyvitamin D3 decreased HCO3- absorption in the rat MTAL from 15.0 to 11.4 pmol/min/mm (P<0.001), an effect significantly potentiated by aldosterone via an ERK-dependent pathway.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: